Exella GmbH & Co. KG (manufacturing, quality control testing, primary packaging, secondary packaging and batch release)

The drug is prescribed for the treatment of acute leukemia in adults and children, specifically acute lymphoblastic leukemia and acute promyelocytic leukemia (acute myeloid leukemia M3).

Dosage form: tablets

ATC: L01BB02